Dr Reddys Laboratories (RDY) Interest & Investment Income (2009 - 2026)

Dr Reddys Laboratories has reported Interest & Investment Income for 18 years, with the latest figure at $31.6 million in Q2 2026.

• On a quarterly basis, Interest & Investment Income rose 12.58% year-over-year to $31.6 million in Q2 2026; TTM through Jun 2026 was $92.9 million, a 6.94% decrease from a year earlier, with the FY2026 full-year figure at $84.0 million, down 4.55% from the prior year.
• Interest & Investment Income was $31.6 million for Q2 2026 at Dr Reddys Laboratories, up from $18.3 million in the prior quarter.
• The five-year high for Interest & Investment Income was $35.0 million in Q2 2022, with the low at $1.9 million in Q3 2022.
• Average Interest & Investment Income over 5 years is $19.4 million, with a median of $18.7 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Interest & Investment Income soared 974.07% in 2022, then slumped 59.79% in 2023.
• Over 5 years, Interest & Investment Income stood at $3.4 million in 2022, then soared by 379.59% to $16.3 million in 2023, then sank by 42.01% to $9.5 million in 2024, then jumped by 150.94% to $23.7 million in 2025, then jumped by 33.12% to $31.6 million in 2026.
• The last three Interest & Investment Income figures came in at $31.6 million (Q2 2026), $18.3 million (Q1 2026), and $23.7 million (Q4 2025), per Business Quant data.